https://www.avient.com/sites/default/files/2023-05/MagIQ Nonwoven Electret Additives Application Bulletin.pdf
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
In order to ensure the middle layer in a face mask can effectively block up to 95% of airborne particles, the material requires the addition of a specific additive prior to the meltblown stage followed by a process known as electret charging.
https://www.avient.com/sites/default/files/2023-05/Cesa Light Diffusion Additives for Automotive - Product Overview.pdf
Contact your local Avient representative and let’s start the development process.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2020-09/oncap-anti-fog-product-bulletin.pdf
Film manufacturers don’t need to add a secondary process to achieve anti-fog properties.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2022-06/Colorant Chromatics FEP UV Laser Marking Product Bulletin.pdf
In addition, this UV laser marking technology for FEP is melt processible and cost effective compared to current PTFE tape wiring solutions for laser marking.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2023-06/Cesa_ Stat Antistatic Additives for Automotive - Application Bulletin.pdf
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
The Cesa Stat Antistatic Additives portfolio provides the following advantages: • Very good processability • Permanently active through the part service time • Not influenced by humidity • Washing resistant • Easy to print • No influence on color, transparent in some polymers • Low dosage • Low VOC’s • Worldwide availability Please contact your local Avient representative for more information on our solutions for the automotive industry or other applications.
https://www.avient.com/sites/default/files/2020-08/silcosperse-ec-product-bulletin.pdf
Lower dosing percentages in SWCNT and MWCNT technologies allow a wider processing and formulation window than with available conventional products.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
The nucleating agents also foster constant process settings throughout part manufacturing with a higher crystallization temperature for improved crystallization speed.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2023-10/Cesa Laser Additives Laser Welding Product Bulletin.pdf
Cesa™ Laser Additives Laser welding solutions Laser plastic welding, also often referred to as transmission welding, is a process of bonding plastic parts using focused laser radiation.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/sites/default/files/2022-07/EHS Committee Charter %28Amended July 2022%29.pdf
Duties and Responsibilities The Committee will: Assessment Process • Periodically review the results of formal assessments by management of the environmental liabilities for which the Company has known or probable environmental exposure and the adequacy of the Company’s financial reserves for environmental liabilities; • Semi-annually review the status of health and safety performance of the Company; • Semi-annually review the status of the Company’s product stewardship programs and performance; • Periodically review the Company’s staffing for its environmental, health and safety assessments and compliance; and 2 • Periodically review new environmental, physical security, health and safety laws and regulations applicable to the Company’s operations and issues or significant developments arising from pending regulatory and citizen group activities.
Compliance Programs • At least annually review the programs and procedures established by the Company that monitor compliance with the Company’s policies, standards and practices, and laws and regulations with respect to safety, health, environmental, physical security and product stewardship, including providing oversight of the systems that are in place to monitor and mitigate the Company’s carbon footprint and physical risks associated with climate change; • Periodically review with management the significant safety, health, environmental, physical security, and product stewardship risks or exposures faced by the Company, if any, and steps taken by management to minimize such risks and exposures to the Company and its constituencies; • At least annually review the status of the Company’s environmental and safety audit process, assessing compliance with Company policies, standards, practices, laws and regulations; and • Periodically review claims, demands, administrative orders and legal proceedings against the Company regarding safety, health, environmental, physical security and product stewardship matters.
Committee Meetings and Action • A majority of the Committee members will be a quorum for the transaction of business. • The action of a majority of those present at a meeting at which a quorum is present will be the act of the Committee. • Any action that may be taken at a meeting of the Committee may be taken by written consent so long as the written consent is unanimously approved and filed with the Corporate Secretary. • The Company’s Senior Vice President, Global Operations and Process Improvement or his/her designee, will be the management liaison to the Committee. • The Committee may appoint subcommittees from time to time as needed, and may delegate authority to such subcommittees or to officers of the Company when appropriate, consistent with applicable laws, regulations and listing standards. • The Corporate Secretary or his/her designee shall be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least two times a year and at such other times as may be requested by its Chair. 3 • The Committee will annually review its charter and recommend any changes to the Governance and Corporate Responsibility Committee.